3D Systems (DDD) investor relations material

Executive summary

• Q1 2026 revenue reached $95.5 million, up 11% year-over-year excluding divestitures, with double-digit growth in Healthcare, Dental, Med Tech, and Aerospace & Defense, and strong gains in printer, parts, and healthcare materials sales.

• Net loss narrowed to $4.4 million from $37.0 million in Q1 2025, reflecting improved operating performance and cost reductions.

• Introduced refreshed product portfolio and new printer systems in both polymers and metals, with rapid adoption and expansion into new geographies.

• Expanded addressable market with U.S. and E.U. regulatory approvals for dental solutions, notably the NextDent 300 platform.

• Significant expansion underway at the Littleton, Colorado facility to meet rising aerospace and defense demand.

Financial highlights

• Q1 consolidated revenue was $95.5 million, up 11% year-over-year, with non-GAAP gross margin at 36.1% and GAAP gross margin at 35.9%.

• Adjusted EBITDA was $2.1 million, a $26 million improvement year-over-year, and non-GAAP loss per share improved to $(0.01) from $(0.21).

• Net loss attributable to shareholders improved by $32.6 million to $4.4 million year-over-year.

• Ended Q1 with $86.5 million in cash and $3.9 million of debt due in Q4 2026.

• Non-GAAP operating expenses were $36.6 million, down 35% year-over-year and 11% sequentially.

Outlook and guidance

• Q2 2026 revenue guidance set at $93–$95 million, with adjusted EBITDA loss expected between $2–$4 million.

• Management targets breakeven or better adjusted EBITDA for the full year, with operating expenses projected to remain stable.

• Sufficient liquidity expected for the next twelve months, with ongoing focus on cost control and operational efficiency.